About this document
Etamicastat: Novel DBH Inhibitor Study by Nuno Palma is a document available to read on EtoBox.
The study investigates the interaction of etamicastat, a novel dopamine-β-hydroxylase (DBH) inhibitor, with human DBH and compares its effects with nepicastat. Both compounds demonstrated mixed-model inhibition of DBH, significantly lowering noradrenaline levels and blood pressure in spontaneously hypertensive rats, with etamicastat showing peripheral selectivity. The findings suggest etamicastat as a promising candidate for antihypertensive therapy due to its favorable pharmacokinetic profile and reduced c
- Author
- Nuno Palma
- Language
- EN